Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programme.

Wuping BaoYingying ZhangJingqing HangYubiao GuoWei TangChunmei YunJingmin DengMeiling JinKefang LaiHuapeng YuMaarten BeekmanXin ZhouMin Zhang

Published in: Therapeutic advances in respiratory disease (2022)

Among patients with predominantly moderate-to-severe asthma managed in tertiary care and were prescribed SABA, 1 in 5 received ⩾3 canisters/year. Fewer patients who received ICS/LABA prescriptions experienced annual exacerbations than those prescribed SABA add-on.

Keyphrases

tertiary care
chronic obstructive pulmonary disease
lung function
cystic fibrosis
high intensity
study protocol
allergic rhinitis
clinical trial
randomized controlled trial